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Abstract
Background. Adolescents living with HIV (ALHIV) experience a high burden of mental
health disorder which is a barrier to antiretroviral therapy adherence. In Zimbabwe, trained,
mentored peer supporters living with HIV (Community Adolescent Treatment Supporters –
CATS) have been found to improve adherence, viral suppression and psychosocial well-being
among ALHIV. The Friendship Bench is the largest integrated mental health programme in
Africa. We hypothesise that combining the CATS programme and Friendship Bench will
improve mental health and virological suppression among ALHIV compared with the
CATS programme alone.
Methods. We will conduct a cluster-randomised controlled trial in 60 clinics randomised 1:1
in five provinces. ALHIV attending the control arm clinics will receive standard CATS support
and clinic support following the Ministry of Health guidelines. Those attending the interven-
tion arm clinics will receive Friendship Bench problem-solving therapy, delivered by trained
CATS. Participants with the signs of psychological distress will be referred to the clinic for
further assessment and management. The primary outcome is HIV virological failure
(≥1000 copies/ml) or death at 48 weeks. Secondary outcomes include the proportion of ado-
lescents with common mental disorder symptoms (defined as Shona Symptom Questionnaire
(SSQ-14) score ≥8), proportion with depression symptoms (defined as Patient Health
Questionnaire (PHQ-9) score ≥11), symptom severity (mean SSQ-14 and PHQ-9 scores)
and EQ-5D score for health-related quality of life.
Conclusions. This trial evaluates the effectiveness of peer-delivery of mental health care on
mental health and HIV viral load among ALHIV. If effective this intervention has the poten-
tial to be scaled-up to improve these outcomes.Trial registration: PACTR201810756862405. 08
October 2018.
Background
Whilst 80% of the estimated 64000 adolescents living with HIV (ALHIV) in Zimbabwe have
been initiated on antiretroviral therapy (ART), a recent study of 500 adolescents on ART
found 48% had virological failure (VF) (Mavhu et al., 2017). Globally, adolescents are the
age group with the highest rate of HIV treatment failure, and the only age group in which
HIV-related mortality is not decreasing (Joint United Nations Programme on HIV/AIDS
(UNAIDS), 2016). This is partly due to the multiple challenges to adherence faced by
ALHIV (Hudelson and Cluver, 2015) including late disclosure, poor treatment literacy, lack
of support, stigma, pill fatigue and side effects.
Common mental disorders (CMDs, i.e. depression and anxiety) can inhibit adherence to
medication including ART, possibly by their effects on self-efficacy and motivation(Wagner
et al., 2017), as supported by Social Cognitive Theory and the Information, Motivation and
Behavioural skills (IMB) model of health behaviour. However, the impact and management
of depression among ALHIV, including its impact on ART adherence and viral suppression,
have not been widely studied (Willis et al., 2018). Studies among ALHIV in sub-Saharan
Africa have found an association between mental health disorders and poor ART adherence
or VF (Lowenthal et al., 2012; Mutumba et al., 2016). In Zimbabwe, 63% of 141 ALHIV
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aged 13–18 were above the ‘at-risk threshold’ for CMD symptoms
(Shona Symptom Questionnaire (SSQ-14) score ≥8), and those
with CMD were less likely to have good reported ART adherence
( p = 0.04) (Mavhu et al., 2013). In Johannesburg, 343 ALHIV
aged 13–19 years accessing five paediatric ART clinics were
assessed using standardised measures and found that 27% were
symptomatic for depression, anxiety and post-traumatic stress
disorder, and a further 24% indicated the signs of suicidality
(Woollett et al., 2017).
Among Zimbabwean ALHIV, CMD symptoms are associated
with poor self-reported ART adherence (Mavhu et al., 2013),
and a pilot study found evidence of improved virological suppres-
sion following combined depression and adherence counselling
(Abas et al., 2018). There is some evidence that treating CMDs
can improve ART adherence and virological suppression in
adults. Depression treatment was associated with improved ART
adherence in a meta-analysis of 29 studies from the USA,
although there was no evidence of an effect when only the 15 ran-
domised controlled trials were included (Sin and DiMatteo, 2014).
Evidence from Africa is scant. In Uganda, depression alleviation
at 12 months was associated with improved ART adherence,
and the relationship was mediated by adherence self-efficacy
(Wagner et al., 2017). This result suggests that depression treat-
ment may improve participants’ ability and confidence to take
ART, which in turn improves adherence. ART adherence and
virological suppression improved after depression treatment of
41 PLHIV in Cameroon (Gaynes et al., 2015).
In Zimbabwe, as in many other countries, there is limited
understanding of the mental health needs of adolescents, includ-
ing those living with HIV. There is also no system for the identi-
fication, referral and management of ALHIV and mental illness
(Mangezi and Chibanda, 2010). With only 12 practising psychia-
trists in Zimbabwe, innovative approaches to the provision of
mental health services are essential. In the proposed trial, we
will evaluate the impact of two existing psychosocial interventions
delivered by lay workers on ART adherence among ALHIV.
The Zvandiri programme, developed by the Private Voluntary
Organisation Africaid, is a model of differentiated clinical service
delivery for children, adolescents and young people living with
HIV in Zimbabwe and has been cited as a ‘best practice’ intervention
by the WHO (Willis et al., 2018; World Health Organisation, 2019)
and adopted or adapted in eight countries in the region. At the fore-
front of Zvandiri are trained, mentored peer supporters aged 18–24
years old and living with HIV. These peer supporters are known as
Community Adolescent Treatment Supporters (CATS). CATS are
integrated within the clinics and surrounding communities and gen-
erate demand for HIV services across the cascade (Willis et al.,
2018), supporting ART initiation, adherence, linkage and retention
in care for their caseload of children, adolescents and young people.
This CATS model results in improved adherence, retention (Willis
et al., 2019) and virological suppression (Mavhu et al., 2020)
among ALHIV compared with adolescents receiving standard of
care alone. CATS are actively engaged in the development and
implementation of their own peer-led mental health intervention
in response to the needs of their peers. To achieve this, they aim
to build on their existing experience as peer counsellors.
The Friendship Bench is a low-intensity mental health inter-
vention delivered by trained and supervised lay health workers
(Chibanda et al., 2015). It is based on cognitive behavioural ther-
apy principles with an emphasis on problem-solving therapy
(PST) (Chibanda et al., 2011). A cluster-randomised controlled
trial showed it was effective for treating symptoms of CMDs
(i.e. depression and anxiety disorders), and improving quality of
life, among adults (Chibanda et al., 2016d). Due to its success
in the last 10 years, the Friendship Bench has been scaled-up to
over 70 primary health care facilities in Zimbabwe (Chibanda
et al., 2016c). The Friendship Bench is the only evidence-based
mental health intervention currently scaled up in Zimbabwe
(Chibanda et al., 2016c) and is being adopted by other countries
including Malawi, Tanzania and the USA. Zvandiri aims to adopt
it for its CATS by training and mentoring them in PST.
Method
Overall aims and study hypothesis
The aim of the trial is to evaluate the feasibility and effectiveness
of a peer-led mental health support intervention on virological
suppression, mental health and quality of life in ALHIV in
Zimbabwe. We will evaluate whether training and mentoring
the existing CATS in PST will reduce VF and prevalence and
severity of CMDs at 48 weeks among ALHIV in Zimbabwe, com-
pared with standard CATS care. The primary hypothesis is that
the CATS-PST intervention will be more effective than standard
CATS care in reducing the proportion of ALHIV who have
died or who have VF at 48 weeks (defined as a viral load
⩾1000 copies/ml). The secondary hypotheses are that adolescents
receiving the CATS-PST intervention will have (i) reduced preva-
lence and severity of depression and/or anxiety symptoms (using
the SSQ-14 and PHQ-9 scales) and (ii) improved health-related
quality of life, compared with adolescents receiving standard
CATS care at 48 weeks after enrolment.
Trial outcomes
Primary outcome
The proportion of adolescents with VF (defined as viral load >100
copies/ml) or death at 48 weeks (endline).
Secondary outcomes
• The proportion of adolescents with CMD symptoms (defined as
SSQ-14 score ≥8), and the mean SSQ-14 and PHQ-9 scores.
• The proportion of adolescents with depressive symptoms
(defined as PHQ-9 score ≥11).
• The mean total score for health-related quality of life measured
using the EQ-5D.
In the original trial protocol, the cut-point for the CMD symp-
toms outcome was an SSQ-14 score ≥7, but a cut-point of ≥8
will be used here, as this was the optimal cut-off in a study involv-
ing adolescents in Zimbabwe with affective disorders (Langhaug
et al., 2010).
Trial setting
The trial will be conducted in 10 districts of Zimbabwe across five
provinces: Mashonaland East (Murewa district), Midlands
(Gokwe South and Kwekwe districts), Matabeleland North
(Hwange district), Matabeleland South (Beitbridge, Gwanda and
Matobo districts) and Masvingo (Chiredzi, Chivi and Zaka dis-
tricts). In each district, the Zvandiri programme is operational
in six health centres, four rural and two urban. The 60 health cen-
tres (all referred to as ‘clinics’ here) comprise 20 hospitals, 20
clinics and 20 rural health centres.
2 Silindweyinkosi Chinoda et al.
https://www.cambridge.org/core/terms. https://doi.org/10.1017/gmh.2020.14
Downloaded from https://www.cambridge.org/core. IP address: 89.240.73.234, on 03 Sep 2020 at 15:46:46, subject to the Cambridge Core terms of use, available at
Trial design
The study will be a cluster-randomised controlled trial with health
centre as the unit of randomisation. The 60 clinics will be rando-
mised (1:1 allocation within the district) to either CATS-PST sup-
port or standard CATS support, stratified by 10. Randomisation
will be performed by an independent statistician using a pre-
written Stata do-file. Fourteen ALHIV aged 10–19 years will be
recruited per clinic (total = 840) as described in the Baseline
Procedures section (Fig. 1).
Eligibility criteria
• Inclusion criteria: ALHIV aged 10–19 years, eligible for ART
(i.e. either starting or already on ART), with SSQ-14 score
≥7, and able to provide written informed assent for those
aged 10–17 and their caregiver be able to provide written
informed parental/caregiver consent. Those aged 18–19 years
will be asked for written informed consent.
• Exclusion criteria: Participants will not be eligible if they are
unable to comprehend the nature of the study in either
English, Shona or Ndebele, are currently in psychiatric care, or
end-stage AIDS, current psychosis, intoxication and/or dementia.
All those excluded for medical reasons will be referred for appro-
priate care to one of two tertiary facilities in Harare.
Screening and enrolment
From the 60 clusters, a list of potentially eligible participants will
be created from the ALHIV already registered with Zvandiri.
Mobilisation of potential participants will be done by CATS dur-
ing home visits to encourage both the participant and caregivers
(for minors aged 10–17 years) to come to the facility on set days.
Additionally, potential participants who are not already registered
with Zvandiri will be sensitised about the study in the
Opportunistic Infection (OI) department. After pre-screening
for eligibility, all potential participants and their caregivers will
be invited to a trial orientation meeting where the details of the
trial will be explained by an experienced Zvandiri mentor.
Subsequently, potential participants will be screened for CMD
symptoms by the research team using the SSQ-14. Eligible adoles-
cents and caregivers who opt to take part in the trial will be asked
to provide written consent and assent and will be booked for
enrolment procedures and baseline assessments. Those who are
not eligible for the trial will not be re-screened. Participants will
be enrolled in the study over January to March 2019, in both
arms concurrently
All participants attending clinics allocated to the control arm
will receive Zvandiri standard care which entails ART, adherence
support and counselling from clinic-based nurses and primary
counsellors as set out in the prevailing Ministry of Health and
Child Care (MoHCC) guidelines (Ministry of Health and Child
Care, 2016), plus counselling and home-based support from
trained, mentored CATS, monthly support groups, weekly short
message services (SMS) and weekly home visits.
All participants attending clinics in the intervention arm will
receive the usual Zvandiri standard care plus PST. CATS will be
trained and receive continued supervision in the delivery of the
PST intervention in this arm. In both arms, ALHIV presenting
with the signs of psychological distress will be referred by CATS
to the clinic as per standard MoHCC and Zvandiri procedures
for further assessment and management. This will include
follow-up by a trained mental health nurse, where available.
Psychological distress is defined as a report of visual/auditory hal-
lucinations or suicidal ideation on the SSQ-14, or a score of 21 or
higher on the PHQ-9.
Intervention
The CATS-PST 6-session intervention will be adapted from the
four-phase Friendship Bench programme (Verhey et al., 2015;
Chibanda et al., 2016b). In the first phase, kuvhura pfungwa
(opening the mind), the CATS will help the participant to under-
stand what is happening in her or his life and encourage her or
Fig. 1. Study design.
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him to share what is going on and how she or he feels about it. In
the second phase (kusimudzira), the participant is helped to
choose one problem to work on, they will then help the partici-
pant brainstorm for possible solutions. In the third phase, kusim-
bisa, the CATS with the participant focuses on a detailed solution
selection and devising a SMART action plan. In the last phase of
kusimbisisa, participants who have completed 4–6 PST sessions
are invited to take part in the 6-week Circle Kubatana Tose
(Holding Hands Together) support group where people facing
similar life challenges who have all gone through the counselling
can share their stories and spend time together in a safe and pro-
tected environment while learning a craft skill (Chibanda et al.,
2016c). The intervention will also adopt inputs gathered during
the formative work to address the specific needs of the ALHIV.
The adapted intervention will be fully described in a separate
paper. Sixty CATS (two per intervention clinic) will be trained by
the Friendship Bench team in the newly adapted CATS-PST
intervention. We will use the training model previously used for
scaling up the Friendship Bench to over 70 primary care facilities
(Chibanda et al., 2016c). The training programme lasts for 3
weeks and makes use of role play, pre and post-tests, group ses-
sions and one-on-one sessions for those who have difficulties.
The curriculum will include the use of PST with ALHIV and
how to make referrals to mental health services. The CATS are
currently working in these sites and have already been selected
based on their readiness and capacity to provide peer counselling.
Weekly nurse-led group supervision and monthly supervision
from a mental health specialist will be provided. The CATS will
complete a brief evaluation on their experiences of delivering
the intervention.
Sample size, power and randomisation
We aim to recruit 840 ALHIV, on ART from 60 clinics in 10 dis-
tricts. Based on baseline results of the previous trial (Mavhu et al.,
2020), we have assumed that 43% of participants will have VF at
48 weeks (endline) in clinics offering standard CATS support
arm, within-clinic cluster coefficient of variation of 0.25, and
15% loss to follow-up (i.e. 14 participants recruited per clinic,
with 12 seen at endline). This sample size provides 85% power
to detect a 30% prevalence of VF in the CATS-PST support
arm after 48 weeks (Table 1). The sample size also provides
85% power to detect a difference in proportion with VF of 36%
in the standard CATS arm v. 24% in the CATS-PST arm. The
sample size provides 87% power to detect a difference in the pro-
portion with CMD symptoms at 48 weeks of 16% in the standard
CATS arm and 8% in the CATS-PST arm.
Data collection
A finger prick blood sample will be collected from all eligible
recruited study participants at baseline and endline and
transported to Harare Hospital as a dried blood spot sample for
an HIV viral load test at the National Microbiology Reference
Laboratory. CMD symptoms will be measured by the SSQ-14
which has been used extensively in Zimbabwe as a screening
tool with reliable sensitivity and specificity (Chibanda et al.,
2016a). The SSQ-14 is a dichotomous 14-item questionnaire, ori-
ginally developed and validated in Shona (Chibanda et al.,
2016a) and used largely at primary health care settings in
Zimbabwe. Based on a validation study among ALHIV in
Zimbabwe, we will use a cut-point of ≥8 which had a sensitivity
of 85% and a specificity of 80% against a gold standard of major
or minor depression with significant dysfunction on the Mini-
International Neuropsychiatric Interview for Children and
Adolescents (MINI-KID) (unpublished data). Clinical diagnosis
of depression symptoms will be measured by the Patient
Health Questionnaire (PHQ-9). The PHQ-9 is a nine-item
Likert scale used to measure depression symptoms (Kroenke
et al., 2001) and has been validated in Shona (Chibanda et al.,
2016a). The PHQ-9 will be used as a secondary outcome measure
for depression symptoms at 12 months with a cut-point of ⩾11
(Kroenke et al., 2001). Health, disability and health-related qual-
ity of life will be measured using the EQ-5D. We will also collect
data on
• demographic and social characteristics including the level of
caregiver and household support, food insecurity, HIV status
disclosure
• experience of stigma
• clinical information including ARV regimen prescribed and
experience of treatment switching, adherence practices.
The study has a qualitative component to answer critical
questions around the feasibility of this peer-led intervention,
the experiences of CATS when delivering the intervention,
necessary modifications to the PST model itself in order to be
delivered effectively by young people to adolescents and the sup-
port required by CATS. Young adolescents may have difficulty
examining and articulating their experiences as well as listing
their different problems when asked about them directly. For
these adolescents, it may be more effective to elicit their pro-
blems using drawings. At endline, we will conduct two focus
group discussions, each of about 10 participants, on their
experiences of being supported by the CATS using PST. The dis-
cussion will be recorded and analysed. Participants will be ran-
domly selected and give consent to join in the focus group
discussions.
Case reviews
As part of the intervention, all the CATS providing PST in the
intervention arm will be visited by the Zvandiri Mentor on a
weekly or bi-weekly basis to review individual cases. This review
will include a case discussion, review of the case file documenta-
tion and discussion around the challenges and success experi-
enced by the CATS. Twenty CATS (10 male and 10 female),
two per district, will be purposively selected from the 60 interven-
tion arm CATS for audio recording of these case reviews through-
out the 12 months. These recordings will be transcribed verbatim,
translated and analysed to provide an in-depth understanding of
CATS experience of delivering PST for their clients, implementing
fidelity and the range of problems and solutions identified by
their clients.
Table 1. Power of the study if 840 ALHIV are recruited in 60 clinics (14 per clinic;
12 seen at 12 months)
% with VF in intervention arm % with VF in control arm Power
30% 43% 85%
31% 43% 78%
32% 45% 83%
24% 36% 85%
4 Silindweyinkosi Chinoda et al.
https://www.cambridge.org/core/terms. https://doi.org/10.1017/gmh.2020.14
Downloaded from https://www.cambridge.org/core. IP address: 89.240.73.234, on 03 Sep 2020 at 15:46:46, subject to the Cambridge Core terms of use, available at
Audio diaries
At the beginning of the study, 10 CATS will be purposively
selected and invited to record an audio over a 2-week period
at three different time points throughout the study to describe
their experiences of delivering the intervention to their clients.
The CATS’ audios will be recorded in the language of their
choice, transcribed verbatim and translated then analysed
(Table 2).
Data management and analysis
An ODK form will be developed and loaded onto Android
phones for data collection. Ten data clerks will be trained to cap-
ture data using the ODK questionnaire. Data will be uploaded to
the cloud and exported to Stata for analysis.
Quantitative analysis will be at the individual level. The pri-
mary comparison will be the proportion of participants with
VF or death at 48 weeks between arms. Binary outcomes will be
estimated as prevalence ratios using random-effects logistic
regression, adjusting for clinic as a random effect, district as a
fixed effect, and for baseline viral load and baseline score of
PHQ-9 or SSQ-14 as appropriate. Variables associated with
loss-to-follow-up will also be adjusted for. For continuous out-
comes, analogous analyses will be conducted using mixed-effects
linear regression.
The focus group discussions, audio diaries and PST sessions
will be recorded and transcribed for analysis. All case reporting
forms, reports and study-related records will be identified by
coded number to maintain confidentiality. All records will be
kept in locked file cabinets, all computer entries will be done
with coded numbers only with limited computer access to study
personnel. Clinical information will not be released to any party
without written permission and all patient identifiers removed.
All recordings and drawings will be kept in a lockable cabinet,
and destroyed after use.
Ethical considerations
This protocol will be subject to review and approval by institu-
tional review boards at all participating institutions, including
the Medical Research Council of Zimbabwe. Referral for social
protection services if abuse or exploitation is uncovered at any
point during the study will be made to the relevant authorities
and or professionals. Adolescents in the control group who pre-
sent with depression will be managed by their existing clinic ser-
vices. Participants referred for further care will not be excluded
from the study but will receive the extra input from either a
psychiatrist or clinical psychologist in addition to the PST,
while in the control arm, individuals will be referred to a tertiary
facility offering psychiatric services as part of standard care in the
event that the clinic staff are unable to manage the cases. Once the
study has been completed, it is expected that CATS in the control
arm clinics will also be trained in the PST intervention, so that
control arm participants also receive the same intervention, if it
is found to be effective.
Africaid and the study team will always adhere to the best
interest of the child principle. This study will involve highly vul-
nerable adolescents – those living with HIV and mental illness,
and CATS who themselves are living with HIV and their right
to confidentiality, privacy, respect and access to services will
always be upheld. Written informed consent and assent will be
obtained from all study participants prior to enrolment in the
study. If participants are under 18, assent will be obtained along
with written parental or caregiver consent. The written assent
and consent forms will include assent and consent for any photo-
graphs and/or personal stories collected and shared throughout
the duration of the study. Patient identifying information will
not be collected. At the time of analysing data and publication
of the results of the study, the name or identity of participants
will not be used. Participants wishing to withdraw from the
study will be allowed to do so with no effect on their subsequent
care.
Discussion
To our knowledge, there is one pilot trial (Betancourt et al., 2017)
and one published protocol of a trial (Sam-Agudu et al., 2017) to
improve mental health among ALHIV in Africa. A pilot rando-
mised controlled trial in Rwanda found that children aged 7–17
who were affected by HIV benefitted from family-based mental
health promotion. However, only 21 children (12% of the sample)
were living with HIV. In Nigeria, a planned trial of coordinated
transition from paediatric to adult HIV care includes mental
health as a secondary outcome.
Our trial is the first to prospectively enrol ALHIV who screen
positive for CMD symptoms. The results of the study will show
whether it is feasible for CATS to deliver PST to their peers on
ART who have symptoms of CMD. The difference in SSQ-14
and PHQ-9 score will show the effectiveness of this intervention
on CMD symptoms among ALHIV in Zimbabwe.
This research aims to address key challenges related to ART
adherence and virological suppression for ALHIV. The trial has
several methodologic strengths. It is large, well powered and rep-
resentative of the whole country. A cluster-randomised design was
used because the intervention is implemented through training
CATS who are already based at specific clinics. The trial has a bio-
logical endpoint (viral load) as well as the secondary outcomes of
CMD symptoms and quality of life. As a limitation, complete
blinding is impossible. Data analysts will be unaware of which
Table 2. Enrolment, intervention and assessment schedule
Time
Jan–Mar
2019
Jan–Dec
2019
Jan–Mar
2020
Enrolment
Eligibility screen X
Informed consent X
Interventions
Standard CATS X
CATS-PST X
Assessments
Viral load X X
Health-related quality
of life
X X
SSQ-14 cut-point
of ≥8
X X
EQ 5D X X
PHQ-9 cut-point
of ≥11
X X
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clinics within a district share a trial arm, and which arm is which,
until after the publication of an analytical plan.
Operationally, the greatest strength of the trial is the network
of CATS already integrated into primary care clinics across
Zimbabwe, with training and mentoring programme by
Africaid. A cluster-randomised controlled trial of the effectiveness
of CATS care compared to clinic-based care on virological sup-
pression has recently been completed (Mavhu et al., 2020). A
logistic limitation is that some adolescents will have mental health
problems requiring more complex treatment than CATS can pro-
vide, including medication. A referral mechanism is in place, but
mental health care availability is limited and inequitable.
The Friendship Bench programme was originally developed in
Harare and delivered by health advisors who were primarily older
women. A cluster-randomised controlled trial in adults found it
to be highly effective at reducing symptoms of CMDs and depres-
sion (Chibanda et al., 2016d). Importantly, it was equally effective
for the 40% of trial participants who were living with HIV, and for
the youngest participants (aged 18–22) (Chibanda et al., 2016c).
This supports the theory that an adaptation of the programme
will benefit ALHIV. Lessons learned from the scale-up of
Friendship Bench and its expansion into rural areas show that
working with a dynamic group of younger people who have dif-
ferent life challenges than those of the lay health workers bring
in a new dimension in training younger people to be peer
counsellors.
Consent for publication
There will be a statement of consent to be audio taped for adoles-
cents in the study. Those aged 18 and 19 years will give adult con-
sent and in case of younger participants (10–17 years) both the
child and parental or caregivers consent will be sought.
Availability of data and materials. Not applicable.
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